TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #DeepBiology–TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks